| ? |
B3galt1tm1(KOMP)Vlcg
|
|
|
mutant strain
|
KOMP
|
2
|
B3galt1tm1(KOMP)Vlcg
|
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1
|
targeted mutation
|
| ? |
B3galt1tm1e(KOMP)Wtsi
|
|
|
mutant strain
|
KOMP
|
2
|
B3galt1tm1e(KOMP)Wtsi
|
targeted mutation 1e, Wellcome Trust Sanger Institute
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1
|
targeted mutation
|
| 2
|
B3galt1tm1a(KOMP)Wtsi
|
targeted mutation 1a, Wellcome Trust Sanger Institute
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1
|
targeted mutation
|
| ? |
CMHD ES cell lline GT-256G1
|
|
|
unclassified
|
CMMR
|
2
|
Gt (256G1) Cmhd
|
gene trap 256G1, Centre for Modeling Human Disease
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1
|
gene trap
|